Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

UCITS Alternative Index Global is up +0.87% in February, +2.25% YTD

Tuesday, March 06, 2012
Opalesque Industry Update - In February, the UCITS Alternative Index Global is up 0.87% while the UCITS Alternative Index Fund of Funds is up 0.99%.

The UCITS Alternative Index Global is up 0.87% in February, continuing its good run since the beginning of the year (up 1.37% in January). The Fund of Funds Index is up 0.99% bringing its year to date performance to 1.17%. For the second time this year, all strategies end the month with gains. Emerging Markets, Commodities and Long/Short Equity are the best performing strategies, up respectively 2.12%, 1.39% and 1.04%. Emerging Markets is also the best YTD performer with a progression of 6.25%. It is followed by Commodities and Long/Short Equity. As in January, CTA and Volatility post moderate gains compared to the other strategies.

The UAI Blue Chip is up 1.49% in February (2.78% YTD), outperforming the UAI Funds of Funds as well as most UAI single strategy benchmarks.

The UAIX indices perform far better than the overall market in February. The UAIX CTA and UAIX Volatility are up 3.41% and 1.75% respectively. On a year to date basis, the UAIX CTA is now up 4.24%, compared to 0.66% for the UAI CTA. The UAIX Long/Short Equity is up 3.81%, compared to 2.75% for the UAI Long/Short Equity. Not surprisingly, UAIX indices are more volatile than their UAI counterparts as they are based on a small number of constituent funds.

The total assets managed by UCITS hedge funds have increased by more than EUR 3 billion this month to reach EUR 120 billion. At the end of February 2012, the UCITS Alternative Index is composed of more than 830 constituent hedge funds and funds of hedge funds. Please find below the monthly performance of the UCITS Alternative Index of February 2012...Full performance table:Source

PD

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for